This biotech stock is set to nearly quadruple on the back of its advanced gene therapy products, says Cantor Fitzgerald.
This biotech stock is set to nearly quadruple on the back of its advanced gene therapy products, says Cantor Fitzgerald
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Business Business Latest News, Business Business Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Wall Street drifts as stocks continue to follow the bond market's leadWall Street is drifting in mixed trading, continuing a months-long run where it’s followed the cue of the bond market.
Source: latimes - 🏆 11. / 82 Read more »
Wall Street climbs as bond selloff eases, earnings lift moodU.S. stocks rose on Tuesday as a selloff in U.S. Treasuries eased, while upbeat forecasts from Verizon, Coca-Cola and others boosted optimism about corporate America's health in the face of slowing economy and higher inflation.
Source: Reuters - 🏆 2. / 97 Read more »
Wall Street climbs after profits at big companies top forecastsVerizon jumped 7% after saying it increased its number of broadband subscribers by 20% and earned more than analysts expected during the summer.
Source: latimes - 🏆 11. / 82 Read more »